CampbellCell / Therapeutic Solutions, Campbell Neurosciences - LARVOL DELTA

Therapeutic Solutions International Spin Off Campbell Neurosciences Announces Novel Mechanistic Data on CampbellCell Stem Cell Therapy for Schizophrenia (Businesswire) - "Therapeutic Solutions International (TSOI) Spin Off Company Campbell Neurosciences announced new data, covered by its previously filed patents, demonstrating that CampbellCell universal donor stem cells reduce symptoms of schizophrenia in an animal model through stimulation of immune modulation and production of the cytokine brain derived neurotrophic factors (BDNF). In a series of experiments, it was demonstrated that CampbellCell administration resulted in upregulated production of the cytokine interleukin-4, which was needed to reduce the inflammatory cytokine interleukin-17 and to suppress schizophrenia development."

Preclinical • CNS Disorders • Schizophrenia

Therapeutic Solutions International Subsidiary Campbell Neurosciences Reports Positive Preclinical Data in Animal Model of Schizophrenia Using Proprietary Universal Donor Mesenchymal Stem Cell (PRNewswire) - "Therapeutic Solutions International...announced today new data covered by its previously filed patents supporting the use of mesenchymal based stem cell therapy for schizophrenia...The Company is working towards filing with the FDA an Investigational New Drug (IND) application to administer the stem cells in patients who are non-responsive to electroconvulsive therapy."

Preclinical • CNS Disorders • Schizophrenia